Lack of C3 affects Th2 response development and the sequelae of chemotherapy in schistosomiasis

Journal of Immunology

Volumn 170, Issue 1, 2003, Pages 470-476

  La Flamme, Anne Camille ^a,c   MacDonald, Andrew S ^a,d   Huxtable, Clive R ^a   Carroll, Michael ^b   Pearce, Edward J ^a,e  

^a Animal Health Diagnostic Center   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; GAMMA INTERFERON; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 5; INTERLEUKIN 6; LYMPHOCYTE ANTIGEN; PRAZIQUANTEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPLEMENT DEFICIENCY; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOPATHOGENESIS; LIVER DISEASE; MORBIDITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCHISTOSOMIASIS; TH2 CELL;

EID: 0037222226     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.1.470     Document Type: Article

References (61)

1. Butterworth, A. E., A. J. Curry, D. W. Dunne, A. J. Fulford, G. Kimani, H. C. Kariuki, R. Klumpp, D. Koech, G. Mbugua, J. H. Ouma, et al. 1994. Immunity and morbidity in human schistosomiasis mansoni. Trop. Geogr. Med. 46:197.
2. Boros, D. L., and K. S. Warren. 1970. Delayed hypersensitivity-type granuloma formation and dermal reaction induced and elicited by a soluble factor isolated from Schistosoma mansoni eggs. J. Exp. Med. 132:488.
3. Grzych, J. M., E. Pearce, A. Cheever, Z. A. Caulada, P. Caspar, S. Heiny, F. Lewis, and A. Sher. 1991. Egg deposition is the major stimulus for the production of Th2 cytokines in murine schistosomiasis mansoni. J. Immunol. 146:1322.
4. Pearce, E. J., P. Caspar, J. M. Grzych, F. A. Lewis, and A. Sher. 1991. Down-regulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schiatosoma mansoni. J. Exp. Med. 173:159.
5. Carroll, M. C. 1998. The role of complement and complement receptors in induction and regulation of immunity. Annu. Rev. Immunol. 16:545.
6. Bottger, E. C., S. Metzger, D. Bitter-Suermann, G. Stevenson, S. Kleindienst, and R. Burger. 1986. Impaired humoral immune response in complement C3-deficient guinea pigs: absence of secondary antibody response. Eur. J. Immunol. 16:1231.
7. Fischer, M. B., M. Ma, S. Goerg, X. Zhou, J. Xia, O. Finco, S. Han, G. Kelsoe, R. G. Howard, T. L. Rothstein, et al. 1996. Regulation of the B cell response to T-dependent antigens by classical pathway complement. J. Immunol. 157:549.
8. Sheerin, N. S., T. Springall, M. Carroll, and S. H. Sacks. 1999. Altered distribution of intraglomerular immune complexes in C3-deficient mice. Immnunology 97:393.
9. Marth, T., and B. L. Kelsall. 1997. Regulation of interleukin-12 by complement receptor 3 signaling. J. Exp. Med. 185:1987.
10. Fischer, M., S. Goerg, L. Shen, A., Prodeus, C. Goodnow, G. Kelsoe, and M. C. Carroll. 1998. Dependence of germinal center B cells on expression of CD21/CD35 for survival. Science 280:582.
11. Kopf, M., S. Herren, M. V. Wiles, M. B. Pepys, and M. H. Kosco-Vilbois. 1998. Interleukin 6 influences germinal center development and antibody production via a contribution of C3 complement component. J. Exp. Med. 188:1895.
12. Rasmussen, K. R., and W. M. Kemp. 1987. Schistosoma mansoni: Interactions of adult parasites with the complement system. Parasite Immunol. 9:235.
13. Vignali, D. A., Q. D. Bickle, M. G. Taylor, G. Tennent, and M. B. Pepys. 1988. Comparison of the role of complement in immunity to Schistosoma mansoni in rats and mice. Immunology 63:55.
14. Marikovsky, M., M. Parizade, R. Arnon, and Z. Fishelson. 1990. Complement regulation on the surface of cultured schistosomula and adult worms of Schistosoma mansoni. Eur. J. Immunol. 20:221.
15. Horta. M. F., F. J. Ramalho-Pinto, and M. Fatima. 1991. Role of human decay-accelerating factor in the evasion of Schistosoma mansoni from the complement-mediated killing in vitro. J. Exp. Med. 174:1399.
16. Laclette, J. P., C. B. Shoemaker, D. Richter, L. Arcos, N. Pante, C. Cohen, D. Bing, and A. Nicholson-Weller. 1992. Paramyosin inhibits complement C1. J. Immunol. 148:124.
17. Fishelson, Z. 1995. Novel mechanisms of immune evasion by Schistosoma mansoni. Mem. Inst. Oswaldo Cruz 90:289.
18. Verity, C. K., A. Loukas, D. P. McManus, and P. J. Brindley. 2001. Schistosoma japonicum cathepsin D aspartic protease cleaves human IgG and other serum components. Parasitology 122:415.
19. Brunet, L. R., F. D. Finkelman, A. W. Cheever, M. A. Kopf, and E. J. Pearce. 1997. IL-4 protects against TNF-α-mediated cachexia and death during acute schistosomiasis. J. Immunol. 159:777.
20. Curry, R. C., P. A. Kiener, and G. L. Spitalny. 1987. A sensitive immunochemical assay for biologically active MuIFN-γ. J. Immunol. Methods 104:137.
21. Schumacher, J. H., A. O'Garra, B. Shrader, A. van Kimmenade, M. W. Bond, T. R. Mosmann, and R. L. Coffman. 1988. The characterization of four monoclonal antibodies specific for mouse IL-5 and development of mouse and human IL-5 enzyme-linked immunosorbent. J. Immunol. 141:1576.
22. Mosmann. T. R., and T. A. Fong. 1989. Specific assays for cytokine production by T cells. J. Immunol. Methods 116:151.
23. La Flamme, A. C., and E. J. Pearce. 1999. The absence of IL-6 does not affect Th2 cell development in vivo, but does lead to impaired proliferation, IL-2 receptor expression, and B cell responses. J. Immunol. 162:5829.
24. 15N]nitrate in biological fluids. Anal. Biochem. 126:131.
25. Pearce, E. J., A. Cheever, S. Leonard. M. Covalesky, R. Fernandez-Botran, G. Kohler, and M. Kopf. 1996. Schistosoma mansoni in IL-4-deficient mice. Int. Immunol. 8:435.
26. Brindley, P. J., and A. Sher. 1987. The chemotherapeutic effect of praziquantel against Schistosoma mansoni is dependent on host antibody response. J. Immunol. 139:215.
27. Brindley, P. J., M. Strand, A. P. Norden, and A. Sher. 1989. Role of host antibody in the chemotherapeutic action of praziquantel against Schistosoma mansoni: identification of target antigens. Mol. Biochem. Parasitol. 34:99.
28. Sheerin, N. S., T. Springall, K. Abe, and S. H. Sacks. 2001. Protection and injury: The differing roles of complement in the development of glomerular injury. Eur. J. Immunol. 31:1255.
29. Prodeus, A. P., X. Zhou, M. Maurer, S. J. Galli, and M. C. Carroll. 1997. Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature 390:172.
30. Fischer, M. B., A. P. Prodeus, A. Nicholson-Weller, M. Ma, J. Murrow, R. R. Reid, H. B. Warren, A. L. Lage, F. D. Moore, Jr., F. S. Rosen, et al. 1997. Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by C1 inhibitor replacement. J. Immunol. 159:976.
31. Da Costa, X. J., M. A. Brockman, E. Alicot, M. Ma, M. B. Fischer, X. Zhou, D. M. Knipe, and M. C. Carroll. 1999. Humoral response to herpes simplex virus is complement-dependent. Proc. Natl. Acad. Sci. USA 96:12708.
32. Kildsgaard, J., T. J. Hollmann, K. W. Matthews, K. Bian, F. Murad, and R. A. Wetsel. 2000. Cutting edge: Targeted disruption of the C3a receptor gene demonstrates a novel protective anti-inflammatory role for C3a in endotoxin-shock. J. Immunol. 165:5406.
33. Nataf, S., S. L. Carroll, R. A. Wetsel, A. J. Szalai, and S. R. Barnum. 2000. Attenuation of experimental autoimmune demyelination in complement-deficient mice. J. Immunol. 165:5867.
34. Klein, M. A., P. S. Kaeser, P. Schwarz, H. Weyd, I. Xenarios, R. M. Zinkernagel, M. C. Carroll, J. S. Verbeek, M. Botto, M. J. Walport, et al. 2001. Complement facilitates early prion pathogenesis. Nat. Med. 7:488.
35. Ochsenbein, A. F., D. D. Pinschewer, B. Odermatt, M. C. Carroll, H. Hengartner, and R. M. Zinkernagel. 1999. Protective T cell-independent antiviral antibody responses are dependent on complement. J. Exp. Med. 190:1165.
36. -/- mice: Enhanced affinity maturation but impaired antibody persistence. J. Immunol. 164:4522.
37. Takabayashi, T., E. Vannier, B. D. Clark, N. H. Margolis, C. A. Dinarello, J. F. Burke, and J. A. Gelfand. 1996. A new biologic role for C3a and C3a desArg: Regulation of TNF-α and IL-1β synthesis. J. Immunol. 156:3455.
38. Karp, C. L., M. Wysocka, L. M. Wahl, J. M. Ahearn, P. J. Cuomo, B. Sherry, G. Trinchieri, and D. E. Griffin. 1996. Mechanism of suppression of cell-mediated immunity by measles virus. Science 273:228.
39. Drouin, S. M., D. B. Corry, J. Kildsgaard, and R. A. Wetsel. 2001. The absence of C3 demonstrates a role for complement in Th2 effector functions in a murine model of pulmonary allergy. J. Immunol. 167:4141.
40. Eglite, S., K. Pluss, and C. A. Dahinden. 2000. Requirements for C5a receptor-mediated IL-4 and IL-13 production and leukotriene C4 generation in human basophils. J. Immunol. 165:2183.
41. Karp, C. L., A. Grupe, E. Schadt, S. L. Ewart, M. Keane-Moore, P. J. Cuomo, J. Kohl, L. Wahl, D. Kuperman, S. Germer, et al. 2000. Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma. Nat. Immunol. 1:221.
42. Xiao, S. H., B. A. Catto, and L. T. Webster, Jr. 1985. Effects of praziquantel on different developmental stages of Schistosoma mansoni in vitro and in vivo. J. Infect. Dis. 151:1130.
43. Tawfik, A. F., C. E. Carter, and D. G. Colley. 1986. Effects of anti-schistosomal chemotherapy on immune responses, protection and immunity. I. Changes in cellular and humoral responses. Am. J. Trop. Med. Hyg. 35:100.
44. Brindley, P. J., and A. Sher. 1990. Immunological involvement in the efficacy of praziquantel. Exp. Parasitol. 71:245.
45. Doenhoff, M. J., J. Modha, J. R. Lambertucci, and D. J. McLaren. 1991. The immune dependence of chemotherapy. Parasitol. Today 7:16.
46. Brindley, P. J. 1994. Relationships between chemotherapy and immunity in schistosomiasis. Adv. Parasitol. 34:133.
47. Bricker, C. S., J. W. Depenbusch, J. L. Bennett, and D. P. Thompson. 1983. The relationship between tegumental disruption and muscle contraction in Schistosoma mansoni exposed to various compounds. Z. Parasitenkd. 69:61.
48. Scheppers, H., R. Brasseur, E. Goormaghtigh, P. Duquenoy, and J.-M. Ruysschaert. 1988. Mode of insertion of praziquantel into lipid membranes. Biochem. Pharmacol. 37:1615.
49. Pax, R., J. L. Bennett, and R. Fetterer. 1978. A benzodiapine derivative and praziquantel: effects on musculature of Schistosoma mansoni and Schistosoma japonicum. Naunyn-Schmiedebergs Arch. Exp. Pathol. Pharmakol. 304:309.
50. Sher, A. a. S. J. 1988. Genetic control of vaccine-induced immunity against a parasitic helminth, Schistosoma mansoni. BioEssays 9:163.
51. Hebert, M. J., T. Takano, A. Papayianni, H. G. Rennke, A. Minto, D. J. Salant, M. C. Carroll, and H. R. Brady. 1998. Acute nephrotoxic serum nephritis in complement knockout mice: relative roles of the classical and alternate pathways in neutrophil recruitment and proteinuria. Nephrol. Dial. Transplant. 13:2799.
52. Keeling, K. L., R. R. Hicks, J. Mahesh, B. B. Billings, and G. J. Kotwal. 2000. Local neutrophil influx following lateral fluid-percussion brain injury in rats is associated with accumulation of complement activation fragmants of the third component (C3) of the complement system. J. Neuroimmunol. 105:20.
53. Shaio, M. F., F. Y. Chang, S. C. Hou. C. S. Lee, and P. R. Lin. 1991. The role of immunoglobulin and complement in enhancing the respiratory burst of neutrophils against Trichomonas vaginalis. Parasite Immunol. 13:241.
54. Chatham, W. W., and W. D. Blackburn, Jr. 1993. Fixation of C3 to IgG attenuates neutrophil HOCI generation and collagenase activation. J. Immunol. 151:949.
55. Czermak, B. J., V. Sarma, C. L. Pierson, R. L. Warner, M. Huber-Lang, N. M. Bless, H. Schmal, H. P. Friedl, and P. A. Ward. 1999. Protective effects of C5a blockade in sepsis. Nat. Med. 5:788.
56. Wettero, J., T. Bengtsson, and P. Tengvall. 2000. Complement activation on immunoglobulin G-coated hydrophobic surfaces enhances the release of oxygen radicals from neutrophils through an actin-dependent mechanism. J. Biomed. Mater. Res. 51:742.
57. Fallon, P. G., L.-F. Tao, M. M. Ismail, and J. L. Bennett. 1996. Schistosome resistance to praziquantel: fact or artifact? Parasitol. Today 12:316.
58. Huang, X. R., S. R. Holdsworth, and P. G. Tipping. 1997. Th2 responses induce humorally mediated injury in experimental anti-glomerular basement membrane glomerulonephritis. J. Am. Soc. Nephrol. 8:1101.
59. Huang, X. R., P. G. Tipping, L. Shuo, and S. R. Holdsworth. 1997. Th1 responsiveness to nephritogenic antigens determines susceptibility to crescentic glomerulonephritis in mice. Kidney Int. 51:94.
60. Barton, P. A., and J. S. Warren. 1993. Complement component C5 modulates the systemic tumor necrosis factor response in murine endotoxic shock. Infect. Immun. 61:1474.
61. Mwatha, J. K., G. Kimani, T. Kamau, G. G. Mbugua, J. H. Ouma, J. Mumo, A. J. Fulford, F. M. Jones, A. E. Butterworth, M. B. Roberts, et al. 1998. High levels of TNF, soluble TNF receptors, soluble ICAM-, and IFN-γ, but low levels of IL-5, are associated with hepatosplenic disease in human schistosomiasis mansoni. J. Immunol. 160:1992.